Financhill
Back

Xenon Pharmaceuticals Quote, Financials, Valuation and Earnings

Xenon Pharmaceuticals Price Quote

$41.21
+0.06 (+3.54%)
(Updated: November 23, 2024 at 6:01 AM ET)

Xenon Pharmaceuticals Key Stats

Buy
61
Xenon Pharmaceuticals (XENE) is a Buy

Day range:
$39.67 - $41.62
52-week range:
$28.20 - $50.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
236.79
P/B ratio:
3.93%

Volume:
335.4K
Avg. volume:
389K
1-year change:
43.23%
Market cap:
$3.1B
Revenue:
$0
EPS:
$-2.82

How Much Does Xenon Pharmaceuticals Make?

Data Unavailable

Is Xenon Pharmaceuticals Growing As A Company?

Data Unavailable

Xenon Pharmaceuticals Stock Price Performance

What Is Xenon Pharmaceuticals 52-Week High & Low?

Xenon Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Xenon Pharmaceuticals?

Is Xenon Pharmaceuticals Cash Flow Positive?

  • What Is XENE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$156.6M
  • What Is Xenon Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Xenon Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$179.1M

Xenon Pharmaceuticals Return On Invested Capital

Data Unavailable

Xenon Pharmaceuticals Earnings Date & Stock Price

Xenon Pharmaceuticals Competitors

Xenon Pharmaceuticals Dividend Yield

Xenon Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2.52%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 57.18
Upside from Last Price: 38.96%

Major Shareholders

  • How many XENE shares are owned by institutional investors?
    122.9M XENE shares are owned by institutional investors
  • How many XENE shares are owned by insiders?
    542.8K XENE shares are owned by insiders